Welcome to the ICIDOSE#2 intercomparison website. This site contains all the information and documents you will require in relation to the intercomparison.
The intercomparisons in internal dosimetry are an invaluable tool for verifying the performance of internal dosimetry services, promoting harmonisation of dose assessments and identifying areas for improvement. ICIDOSE#2 builds on the success of ICIDOSE 2017, which aimed to assess the practical applicability of new technical recommendations issued by the European Commission (RP188).
The objective of ICIDOSE#2 is to assess internal dose using the most recent recommendations (RP188, ICRP OIR Report Series) or the accreditation standards. The intercomparison offers five cases with different levels of complexity, from simple to more challenging scenarios. This approach is intended to address both common and less frequent issues encountered in internal dosimetry.
| Name | Organization | Country |
|---|---|---|
| Derek BINGHAM | AWE | United Kingdom |
| Bastian BREUSTED | KIT | Germany |
| David BROGGIO | IRSN | France |
| Guillaume DROUET | IRSN | France |
| Pavel FOJTIK | SURO | Czech Republic |
| Augusto GIUSSANI | BfS | Germany |
| Simone LÖSCHER | BfS | Germany |
| Jakub OSKO | NCBJ | Poland |
| Anna PÁNTYA | HUN-REN EK | Hungary |
| Tamás PÁZMÁNDI | HUN-REN EK | Hungary |
| Zsófia RÉKASI | HUN-REN EK | Hungary |
| Vendula ROVENSKÁ | SURO | Czech Republic |
| David SPENCER | Nuvia | United Kingdom |
The participation fee for the intercomparison is 550 € (reduced fee for participants from EURADOS sponsoring institutions is 500 €). This fee will ensure the participation of one person from the institute in the workshop planned for the first half of 2025.